Month: January 2023

LOS ANGELES, CALIFORNIA, Jan. 05, 2023 (GLOBE NEWSWIRE) — MetAlert, Inc. (OTC: MLRT), a pioneer in location-sensitive health monitoring devices and wearable technology products for remote patient monitoring, today issued its yearend shareholder update letter. January 5, 2023 Dear Shareholders and Stakeholders, The management of MetAlert would like to thank you for supporting us. We highly value our shareholders and each of you help us fulfill our mission as a “For Profit with Purpose” company. As many of you know, our products positively impact our users and those people who care about them (family, loved ones, caregivers, neighbors, etc.). Your investment in MetAlert makes a difference. We want to walk you through what has transpired over the past year, give you a little insight into the reasoning behind some of the recent actions...

ROSELAND, N.J., Jan. 05, 2023 (GLOBE NEWSWIRE) — Milestone Scientific Inc. (NYSE: MLSS), a leading developer of computerized drug delivery instruments that provide painless and precise injections, today announced the appointment of Neal Goldman as Chairman of the Board of Directors. Mr. Goldman has served on the Company’s board since 2019 and succeeds Leslie Bernhard, who has resigned following years of dedicated service. Mr. Goldman is the President and Founder of Goldman Capital Management, Inc., a family office since 2018, which was previously an investment advisory firm founded in 1985. He was First Vice President of Research at Shearson Lehman Hutton. He has also held senior positions as a money manager and research analyst with a variety of firms including Neuberger Berman, Moseley Hallgarten Estabrook and Weeden, Bruns Nordeman,...

JACKSONVILLE, Fla., Jan. 05, 2023 (GLOBE NEWSWIRE) — Regency Centers Corporation (The “Company”) (NASDAQ: REG) will announce its Fourth Quarter 2022 earnings results on Thursday, February 9, 2023, after the market closes. The Company’s earnings release and supplemental information package will be posted on the Investor Relations section of the Company’s website – investors.regencycenters.com. The Company will host an earnings conference call on Friday, February 10, 2023, at 11:00 a.m. ET.Fourth Quarter 2022 Earnings Conference CallDate: Friday, February 10, 2023Time: 11:00 a.m. ETDial#: 877-407-0789 or 201-689-8562Webcast: 4th Quarter 2022 Webcast LinkReplay Webcast Archive: Investor Relations page under Webcasts & Presentations About Regency Centers Corporation (NASDAQ: REG) Regency Centers is a preeminent...

LITTLETON, Colo., Jan. 05, 2023 (GLOBE NEWSWIRE) — Vivos Therapeutics, Inc. (“Vivos” or the “Company”) (NASDAQ: VVOS), a medical technology company focused on developing innovative treatments for patients suffering from dentofacial abnormalities and/or mild-to-moderate obstructive sleep apnea (OSA) and snoring in adults, today announced that it has entered into a definitive agreement with a single institutional investor to raise approximately $8 million in a private placement offering at a price of $1.20 per unit. Each unit consists of one share of common stock (or a pre-funded warrant to purchase one share of common stock) and one warrant exercisable for one share common stock at a price of $1.20 per share for a period of five years and 6 months from closing. No actual units will be issued in the offering. After the placement...

NEW YORK, Jan. 05, 2023 (GLOBE NEWSWIRE) — Verizon Business today announced its private 5G wireless network is live at The Smart Factory @ Wichita, a new immersive, Industry 4.0 experience center convened by Deloitte*. Verizon works with Deloitte and other Smart Factory ecosystem companies to advance the execution of smart manufacturing and enables manufacturers to quickly adopt state-of-the-art, Industry 4.0 solutions and technologies that drive new business models to boost quality, productivity and sustainability. As a Builder-level collaborator in The Smart Factory @ Wichita ecosystem of 20 world-leading organizations, Verizon intends to leverage this network of companies to help customers across industries innovate their approach to improved connectivity and use of data to improve real-time coordination between people and assets....

AUSTIN, Texas, Jan. 05, 2023 (GLOBE NEWSWIRE) — Atlas Technical Consultants, Inc. (Nasdaq: ATCX) (“Atlas” or the “Company”), a leading Infrastructure and Environmental services provider, announced that L. Joe Boyer, Chief Executive Officer, and Jonathan Parnell, Chief Strategy Officer will participate in the CJS Securities 23rd Annual New Ideas for the New Year Conference, which is being held virtually, on Wednesday, January 11, 2023. Atlas’s presentation at the event will begin at 3:05 PM Eastern time. The live presentation can be accessed here or through the Company’s Investor Relations website at ir.oneatlas.com. About Atlas Technical ConsultantsHeadquartered in Austin, Texas, Atlas is a leading provider of Infrastructure and Environmental Solutions. We partner with our clients to improve performance and extend the lifecycle...

PHILADELPHIA, Jan. 05, 2023 (GLOBE NEWSWIRE) — Cabaletta Bio, Inc. (Nasdaq: CABA), a clinical-stage biotechnology company focused on developing and launching the first curative targeted cell therapies for patients with autoimmune diseases, today announced that Steven Nichtberger, M.D., Chief Executive Officer, will present at the 41st Annual J.P. Morgan Conference being held in San Francisco, CA on Thursday, January 12th at 7:30 a.m. PT (10:30 a.m. ET). A live webcast of the presentation will be available on the News and Events section of the Company’s website at www.cabalettabio.com. Replays of the presentation will be available on the website for 30 days. About Cabaletta Bio Cabaletta Bio (Nasdaq: CABA) is a clinical-stage biotechnology company focused on the discovery and development of engineered T cell therapies that have...

ANDOVER, Mass., Jan. 05, 2023 (GLOBE NEWSWIRE) — MKS Instruments, Inc. (NASDAQ: MKSI), a global provider of enabling technologies that transform our world, announced today that Seth Bagshaw, Senior Vice President, Chief Financial Officer and Treasurer, will participate in a virtual fireside chat at the 25th Annual Needham Growth Conference on Thursday, January 12, 2023, at 2:15 p.m. (EST). A live webcast of the session will be available in the Investor Relations section of the company’s website at https://investor.mks.com/ and a replay of the event will be available for a limited time thereafter. About MKS Instruments MKS Instruments enables technologies that transform our world. We deliver foundational technology solutions to leading edge semiconductor manufacturing, electronics and packaging, and specialty industrial applications....

SIOUX FALLS, S.D., Jan. 05, 2023 (GLOBE NEWSWIRE) — SAB Biotherapeutics (Nasdaq: SABS), a clinical-stage biopharmaceutical company with a novel immunotherapy platform that produces specifically targeted, high-potency, fully-human polyclonal antibodies without the need for human donors, announced today results from a project in collaboration with global biotechnology leader CSL (ASX: CSL), confirming that SAB’s DiversitAb™ platform can generate functional fully-human anti-idiotype polyclonal antibodies that can effectively target and neutralize autoantibodies associated with autoimmune diseases. Autoantibodies are immune system proteins that can mistakenly target the body’s own organs and tissues. Autoantibodies can target almost every part of the body and are found in a wide range of autoimmune diseases, such as lupus, autoimmune...